STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Zentalis’ board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of Zentalis stockholders to elect directors of their choosing.
Zentalis stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
The Café SHEIN FW25 Pop-Up to Take Over Parramatta this MaySYDNEY, April 22, 2025 (GLOBE…
Used ag plastic jugs ready to be collected and recycled by Cleanfarms Farmers' efforts in…
BELMONT, CA, April 21, 2025 (GLOBE NEWSWIRE) -- Notre Dame de Namur University (NDNU), the…
According to Pixalate's research, 'My FitnessPal' ranked at the top on both Google Play Store…
According to Pixalate's research, ‘Gangstar Vegas: World of Crime’ on Google Play Store generated an…
According to Pixalate's research, ‘Pro Des Mots’ led on Apple App Store in France, ‘SimCity’…
This website uses cookies.